NJ Sues Drugmaker, Alleging 'Greed-Driven' Fentanyl Sales
New Jersey on Thursday filed a lawsuit against the pharmaceutical company Insys Therapeutics Inc., alleging the company engaged in a “greed-driven”…
October 05, 2017 at 03:02 PM
4 minute read
Christopher Porrino |
New Jersey on Thursday filed a lawsuit against the pharmaceutical company Insys Therapeutics Inc., alleging the company engaged in a “greed-driven” campaign of consumer fraud and false claims to health insurance carriers to increase its sales for Subsys, a fentanyl-based opioid used to treat cancer-related pain.
The Division of Consumer Affairs, a branch of the state Division of Law and Public Safety, filed the lawsuit against the Chandler, Arizona-based company in Middlesex County Superior Court.
The four-count complaint charges that, despite Subsys only having Food and Drug Administration (FDA) approval for the “narrow” purpose of treating breakthrough cancer pain in opioid-tolerant patients, Insys unlawfully directed its sales force to push Subsys for prescription to a broader patient population—patients suffering any type of chronic pain—and at higher doses, according to a statement released by Attorney General Christopher Porrino.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
- 4'That's Disappointing': Only 11% of MDL Appointments Went to Attorneys of Color in 2023
- 5'You Are Not Alone': 120 Sex Assault Victims Plan to Sue Sean 'Diddy' Combs
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250